EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Genetically diverse influenza antibodies highlight the role of IG germline gene variation and inform population-comprehensive vaccine strategies

Alexandra A Fischer, Martin Corcoran, Philip J M Brouwer, Mark Chernyshev, Rebecca A Gillespie, Andrea Nicoletto, Johannes R Loeffler, James A Ferguson, Ioannis Zygouras, Pradeepa Pushparaj, Alesandra J Rodriguez, Sanjana Narang und 6 weitere

Immunity · 2026

DOI: 10.1016/j.immuni.2026.03.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2026. Verfasst von Alexandra A Fischer und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Influenza Vaccines, Antibodies, Viral, Influenza, Human, Influenza A virus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, Intramural NIH HHS, National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The regular emergence of influenza strains with pandemic potential necessitates vaccines that elicit protective immune responses across genetically diverse human populations. A critical but understudied factor is how germline-encoded variation in immunoglobulin genes shapes the development of neutralizing antibodies. Here, by combining personalized immunoglobulin genotyping with high-throughput paired-chain antibody sequencing from influenza A hemagglutinin (HA)-binding B cells across four donors, using a technique we developed called individualized single-cell analysis of paired expressed antigen receptors (ISCAPE), we demonstrate that B cell responses to HA are highly individual. We identified a common IGHV2-70 polymorphism that impaired the function of a class of neutralizing HA head-directed antibodies. Furthermore, we described HA central stem-targeting broadly neutralizing antibodies that utilize IGHD3-3 recombined with diverse IGHV genes, expanding the known repertoire of stem antibodies and highlighting antibody gene usage population restrictions. We suggest that multi-donor repertoire studies, coupled with personalized immunoglobulin genotyping, can uncover germline-encoded functional variations and help mitigate population vulnerabilities in vaccine design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesAntibodies, ViralInfluenza, HumanInfluenza A virusGenes, ImmunoglobulinHumansHemagglutinin Glycoproteins, Influenza VirusAntibodies, NeutralizingB-LymphocytesGenetic Variation

Stichwörter der Autor:innen

central stemcryo-EM structuresepitopegermline-targetinghemagglutinininfluenzamonoclonal antibodiesneutralizing activitypersonalized IG genotypingpopulation vulnerabilities

Substanzen

Influenza VaccinesAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. Electronic address: martin.corcoran@ki.se.
  • Department of Integrative Structural and Computational Biology, The Scripps Research Institute, San Diego, CA, USA.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands.
  • Department of Integrative Structural and Computational Biology, The Scripps Research Institute, San Diego, CA, USA. Electronic address: juliannahan@scripps.edu.

Förderung

  • NIAID NIH HHS
  • Intramural NIH HHS
  • National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
  • Knut and Alice Wallenberg Foundation
  • Swedish Research Council
  • SciLifeLab
  • U.S. Department of Health and Human Services
  • Vaccine Research Center

Zitieren

APA

Fischer, A. A., Corcoran, M., Brouwer, P. J. M., Chernyshev, M., Gillespie, R. A., Nicoletto, A., Loeffler, J. R., Ferguson, J. A., Zygouras, I., Pushparaj, P., Rodriguez, A. J., Narang, S., van Gils, M. J., Castro Dopico, X., Kanekiyo, M., Ward, A. B., Han, J., & Karlsson Hedestam, G. B. (2026). Genetically diverse influenza antibodies highlight the role of IG germline gene variation and inform population-comprehensive vaccine strategies. Immunity. https://doi.org/10.1016/j.immuni.2026.03.002

Vancouver

Fischer AA, Corcoran M, Brouwer PJM, Chernyshev M, Gillespie RA, Nicoletto A, et al. Genetically diverse influenza antibodies highlight the role of IG germline gene variation and inform population-comprehensive vaccine strategies. Immunity. 2026. doi:10.1016/j.immuni.2026.03.002

BibTeX
@article{Fischer2026,
  author = {Fischer, Alexandra A and Corcoran, Martin and Brouwer, Philip J M and Chernyshev, Mark and Gillespie, Rebecca A and Nicoletto, Andrea and Loeffler, Johannes R and Ferguson, James A and Zygouras, Ioannis and Pushparaj, Pradeepa and Rodriguez, Alesandra J and Narang, Sanjana and van Gils, Marit J and Castro Dopico, Xaquin and Kanekiyo, Masaru and Ward, Andrew B and Han, Julianna and Karlsson Hedestam, Gunilla B},
  title = {Genetically diverse influenza antibodies highlight the role of IG germline gene variation and inform population-comprehensive vaccine strategies},
  journal = {Immunity},
  year = {2026},
  doi = {10.1016/j.immuni.2026.03.002}
}
Kostenlos starten →